用含的分子在瘤细胞膜中向酸,以有效地对抗瘤转移
Xiao-Hong Zhou1,2, Jia-Wei Wang3, Wei You2
1Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
Journal of nanobiotechnology
|May 20, 2025
概括
研究人员开发了一种新分子,2aZn,可以选择性地向瘤细胞膜治疗癌症. 这种创新方法克服了耐药性和转移,对健康组织的损害最小.
科学领域:
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 基于金属的药物,像白金剂一样,是癌症治疗的支柱.
- 对抗药性和瘤转移的无效控制限制了传统的癌症治疗方法.
- 准细胞膜提供了一种克服抵抗和转移的策略,但通常会导致细胞毒性.
研究的目的:
- 开发一种新的含分子,用于选择性瘤细胞杀死.
- 为了研究该分子在克服药物耐药性和瘤转移方面的有效性.
- 评估该分子在正常组织上的安全性.
主要方法:
- 一种含的两性分子 (2aZn) 的选和结构优化.
- 对2aZn在瘤细胞膜上向脂胺素的能力的评估.
- 评估2aZn的细胞毒性,抗转移效应,以及潜在的药物耐药性发展.
主要成果:
- 2aZn选择性地破坏瘤细胞膜,导致各种癌症类型的细胞死亡.
- 在2aZn治疗时观察到正常组织的最小损伤.
- 在多次暴露于2aZn.之后,没有显著的耐药性发展.
- 2aZn通过降低细胞入侵能力,证明了对抗瘤转移的有效性.
结论:
- 含的分子,以2aZn为例,显示出克服瘤耐药性和转移的潜力.
- 2aZn提供了一种新的治疗策略,具有选择性的瘤细胞向和减少副作用.
- 这项研究为设计有效的抗癌药物提供了新的视角.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cell-surface Signaling
51.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


